• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amicus Therapeutics, Inc. - Common Stock (NQ:FOLD)

    14.37 -0.00 (-0.03%)
    Streaming Delayed Price Updated: 3:56 PM EST, Mar 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,849,589
    Open 14.34
    Bid (Size) 14.36 (51,500)
    Ask (Size) 14.37 (39,000)
    Prev. Close 14.37
    Today's Range 14.34 - 14.37
    52wk Range 5.510 - 14.38
    Shares Outstanding 266,555,274
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing ↗
    This clinical-stage biotech develops therapies for rare muscle diseases using its proprietary FORCE platform and research-driven approach. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗
    This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +0.7%
    +0.7%
    1 Month
    +0.5%
    +0.5%
    3 Month
    +46.6%
    +46.6%
    6 Month
    +82.3%
    +82.3%
    1 Year
    +57.3%
    +57.3%

    More News

    Read More
    News headline image
    Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
    From Amicus Therapeutics, Inc.
    Via GlobeNewswire
    Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal ↗
    Via Stocktwits
    News headline image
    Halper Sadeh LLC is Investigating Whether RAPT, CTGO, TBN, FOLD are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026
    From Amicus Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC Reminds Shareholders of JHG, FOLD, RAPT of the Firm’s Investigations
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Should You Buy BioMarin Pharmaceutical Before Feb. 18? ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    Halper Sadeh LLC Encourages PEN, FOLD, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    The Great Unlocking: 2026 Opens with a Historic Surge in Large-Cap M&A Activity
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    News headline image
    Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    BioMarin’s $4.8 Billion Amicus Acquisition: A Strategic Pivot to Rare Disease Dominance
    Via MarketMinute
    Topics Economy Intellectual Property
    News headline image
    Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
    Via MarketMinute
    Topics ETFs Intellectual Property
    News headline image
    Amicus Therapeutics Investment Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amicus Therapeutics, Inc. - FOLD
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    The Liquidity Vacuum: Thin Holiday Trading Sparks Volatility as 2025 Draws to a Close
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Clearwater Analytics Holdings, Inc. (NYSE - CWAN), Katapult Holdings, Inc. (Nasdaq - KPLT), Janus Henderson Group plc (NYSE - JHG), Amicus Therapeutics, Inc. (Nasdaq
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Unusual volume stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    News headline image
    Discover the most active stocks in Friday's session. ↗
    Via Chartmill
    News headline image
    Which stocks are moving on Friday? ↗
    Via Chartmill
    News headline image
    Which stocks are gapping on Friday? ↗
    Via Chartmill
    News headline image
    FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire

    Frequently Asked Questions

    Is Amicus Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Amicus Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Amicus Therapeutics, Inc. - Common Stock trade on?
    Amicus Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Amicus Therapeutics, Inc. - Common Stock?
    The ticker symbol for Amicus Therapeutics, Inc. - Common Stock is FOLD on the Nasdaq Stock Market
    What is the current price of Amicus Therapeutics, Inc. - Common Stock?
    The current price of Amicus Therapeutics, Inc. - Common Stock is 14.37
    When was Amicus Therapeutics, Inc. - Common Stock last traded?
    The last trade of Amicus Therapeutics, Inc. - Common Stock was at 03/02/26 03:56 PM ET
    What is the market capitalization of Amicus Therapeutics, Inc. - Common Stock?
    The market capitalization of Amicus Therapeutics, Inc. - Common Stock is 3.83B
    How many shares of Amicus Therapeutics, Inc. - Common Stock are outstanding?
    Amicus Therapeutics, Inc. - Common Stock has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.